FundingMachineFunding Atlas programme
Clinical Trials Grants Program
FDA Office of Orphan Products Development
JurisdictionUnited StatesFunding typeGrant
Documented facts
Key facts
- Funder
- FDA Office of Orphan Products Development
- Jurisdiction
- United States
- Record type
- Opportunity
- Funding type
- Grant
- Amount
- Not published by the funder
Published rule provenance
Eligibility information
- Country / jurisdiction
Rule not encoded
- Organisation type
Rule not encoded
- Company size
Rule not encoded
- Stage
Encoded condition recorded; read its source quotation.
Eligibility rule, quoted from the funder
This NOFO is intended to support clinical trials of orphan products in all phases of product development (phase 1, 2 and/or 3) for rare diseases with unmet medical needs.
Quoted source- Therapeutic area
Rule not encoded
- Amount sought
Rule not encoded
Further quoted conditions
Eligibility rule, quoted from the funder: area
Only clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling of products to address unmet needs in rare diseases or conditions qualify.Quoted source
Site note: This record is not advice or a funder decision.